Tvardi Therapeutics
TVRD
Tvardi Therapeutics (TVRD) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $5.00 from $15.00 | Jul 30, 2026 |
| Raymond James | Upgraded | Market Perform → Outperform | $10.00 | Jul 8, 2026 |
| BTIG | Maintained | Buy | $15.00 | Jul 7, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $9.00 | Jun 8, 2026 |
| Barclays | Downgraded | Equal-Weight → Underweight | $3.00 from $4.00 | Apr 20, 2026 |
| Piper Sandler | Maintained | Neutral | $3.00 from $4.00 | Apr 1, 2026 |
| Barclays | Maintained | Equal-Weight | $4.00 from $5.00 | Apr 1, 2026 |
| BTIG | Maintained | Buy | $15.00 | Apr 1, 2026 |
| Raymond James | Downgraded | Outperform → Market Perform | — | Oct 14, 2025 |
| BTIG | Maintained | Buy | $15.00 from $55.00 | Oct 13, 2025 |
| Barclays | Initiated Coverage | Overweight | $61.00 | Oct 13, 2025 |
| Raymond James | Initiated Coverage | Outperform | $62.00 | Jul 14, 2025 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | $52.00 | Jul 11, 2025 |
| Piper Sandler | Initiated Coverage | Overweight | $78.00 | Jun 12, 2025 |
| Oppenheimer | Initiated Coverage | Outperform | $65.00 | May 21, 2025 |
| Jones Trading | Initiated Coverage | Buy | $39.00 | Apr 28, 2025 |
| Needham | Downgraded | Buy → Hold | — | Jun 13, 2024 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | — | Jun 13, 2024 |
| Canaccord Genuity | Downgraded | Buy → Hold | $1.00 from $10.00 | Jun 13, 2024 |
| Needham | Maintained | Buy | $5.00 | May 23, 2024 |
Frequently asked questions
What is the latest analyst rating on TVRD?
On Jul 30, 2026, BTIG maintained Tvardi Therapeutics at Buy with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.